US Patent 9334331 Bispecific antibodies

US Patent 12133867 Universal anti-CD22 chimeric antigen receptor engineered immune cells

US Patent 12129300 Antibody variable domains targeting the NKG2D receptor

US Patent 12129297 Antibodies against TIM3 and uses thereof

US Patent 12122840 Method of modifying isoelectric point of antibody via amino acid substitution in CDR

US Patent 12122839 IFNGR binding synthetic cytokines and methods of use

US Patent 12116414 Method of modifying isoelectric point of antibody via amino acid substitution in CDR

US Patent 12116405 Arthritis treatment

US Patent 12018085 Interferon-gamma R2 (IFNGR2) binding molecules comprising single-domain antibodies and method of use thereof to treat autoimmune and inflammatory diseases

US Patent 11987640 Anti-mesothelin antigen-binding molecules and uses thereof

US Patent 11976135 FIXaxFX bispecific antibody with common light chain

US Patent 11964016 Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy

US Patent 11944643 Universal anti-CD22 chimeric antigen receptor engineered immune cells

US Patent 11939384 Antibody variable domains targeting the NKG2D receptor

US Patent 11919969 Bispecific antibodies for factor IX and factor X

US Patent 11911348 Therapeutic agent for cancer

US Patent 11891447 Method for treating cancer using CD14 antagonists

US Patent 11891438 Methods of altering bone growth by administration of Sost or Wise antagonist or agonist

US Patent 11891436 Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

US Patent 11890353 Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of PEG-based therapies